NCT02975466

Comparing the Efficiency of Three Third-generation Supraglottic Airways as an Intubation Route

Completed NA Last updated 9 May 2018

What this trial tests

NA trial testing Insertion of AirQ Blocker and intubation through the device in Difficult Intubation in 150 participants. Completed in 1 January 2018.

Timeline

21 March 2017

Primary endpoint
1 January 2018

1 January 2018

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	150
Start date	21 March 2017
Primary completion	1 January 2018
Estimated completion	1 January 2018
Sites	1 location across Canada

Drugs / interventions tested

• Insertion of AirQ Blocker and intubation through the device
• Insertion of AuraGain and intubation through the device
• Insertion of I-Gel and intubation through the device

Conditions studied

• Difficult Intubation — all drugs for Difficult Intubation →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

18 and older, any sex, with Difficult Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A "can't intubate, can't oxygenate" situation is life-threatening and the physician must be prepared to react quickly. Similarly, a difficult intubation with adequate ventilation is associated with complications. In both of these situation and as recommend by different societies, a supra-glottic airway (SGA) device can be used to help ventilation, or as an intubation conduit to ease the airway access. The objective of this randomized controlled trial is to establish which SGA, between the AuraGain, AirQ Blocker and I-Gel, allows the fastest intubation time in an adult population, with the objective of minimizing complications related to these situations. The investigators will conduct a three-arm trial to compare different outcomes related to the installation of the SGA and its use as an intubation conduit. The results of this trial will inform the anesthesiologist on which device to use on to have close in case of airway emergencies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. A randomized controlled trial comparing three supraglottic airway devices used as a conduit to facilitate tracheal intubation with flexible bronchoscopy.
   Laferrière-Langlois P, Dion A, Guimond É, Nadeau F, et al · · 2023 · cited 4× · PMID 37055702 · DOI 10.1007/s12630-023-02444-z